Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (34) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Summaries of opinion (8) Apply Summaries of opinion filter Withdrawn applications (31) Apply Withdrawn applications filter Orphan designations (69) Apply Orphan designations filter

Product number

Patient safety

Yes (1) Apply Yes filter

Authorisation status

Authorised (348) Apply Authorised filter Refused (1) Apply Refused filter Withdrawn (77) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (6) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (59) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (1) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (13) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (22) Apply Yes filter

Compliance procedure number

Referral name

Referral status

European Commission final decision (9) Apply European Commission final decision filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 20 procedures (5) Apply Article 20 procedures filter Article 31 referrals (4) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (6) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (4) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (5) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (5) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Additional monitoring (618) Apply Additional monitoring filter Biosimilar (96) Apply Biosimilar filter Orphan medicine (267) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

535 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Paediatric investigation plans Remove Paediatric investigation plans filter

Medicine type Generic Remove Generic filter Accelerated assessment Remove Accelerated assessment filter Exceptional circumstances Remove Exceptional circumstances filter Conditional approval Remove Conditional approval filter

Sort by

List item

Human medicine European public assessment report (EPAR): Abecma

idecabtagene vicleucel, Multiple Myeloma; Neoplasms; Cancer; Neoplasms, Plasma Cell; Hemostatic Disorders; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemic and Lymphatic Diseases; Hemorrhagic Disorders; Infectious Mononucleosis; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases
Date of authorisation: 18/08/2021, , , , Revision: 6, Authorised, Last updated: 27/07/2023
List item

Human medicine European public assessment report (EPAR): Abiraterone Accord (updated)

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 26/04/2021, , Revision: 1, Authorised, Last updated: 25/09/2023
List item

Human medicine European public assessment report (EPAR): Abiraterone Krka

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 24/06/2021, , Revision: 2, Authorised, Last updated: 08/03/2023
List item

Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 20/08/2021, , Revision: 4, Authorised, Last updated: 11/09/2023
List item

Human medicine European public assessment report (EPAR): Abrysvo (updated)

Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B, Respiratory Syncytial Virus Infections
Date of authorisation: 23/08/2023, , , Authorised, Last updated: 15/09/2023
List item

Human medicine European public assessment report (EPAR): Actelsar HCT

Telmisartan, hydrochlorothiazide, Essential Hypertension
Date of authorisation: 13/03/2013, , Revision: 15, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Adakveo

Crizanlizumab, Anemia, Sickle Cell
Date of authorisation: 28/10/2020, , , , Revision: 6, Withdrawn, Last updated: 21/08/2023
List item

Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009, , Revision: 11, Authorised, Last updated: 08/06/2022
List item

Human medicine European public assessment report (EPAR): Ambrisentan Mylan

ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019, , Revision: 4, Authorised, Last updated: 26/04/2023
List item

Human medicine European public assessment report (EPAR): Amifampridine SERB

amifampridine phosphate, Lambert-Eaton Myasthenic Syndrome; Paraneoplastic Syndromes, Nervous System; Nervous System Neoplasms; Paraneoplastic Syndromes; Nervous System Diseases; Autoimmune Diseases of the Nervous System; Neurodegenerative Diseases; Neuromuscular Diseases; Neuromuscular Junction Diseases; Immune System Diseases; Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Cancer; Neoplasms
Date of authorisation: 19/05/2022, , Authorised, Last updated: 24/05/2022
List item

Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan

Amlodipine besilate, valsartan, Hypertension
Date of authorisation: 22/03/2016, , Revision: 11, Authorised, Last updated: 17/08/2023
List item

Human medicine European public assessment report (EPAR): Amversio

betaine, Homocystinuria
Date of authorisation: 05/05/2022, , Authorised, Last updated: 08/06/2023
List item

Human medicine European public assessment report (EPAR): Anagrelide Mylan

Anagrelide hydrochloride, Thrombocythemia, Essential
Date of authorisation: 15/02/2018, , Revision: 8, Authorised, Last updated: 11/05/2023
List item

Human medicine European public assessment report (EPAR): Apixaban Accord

Apixaban, Venous Thromboembolism; Stroke; Arthroplasty
Date of authorisation: 23/07/2020, , Revision: 2, Authorised, Last updated: 19/05/2022
List item

Human medicine European public assessment report (EPAR): Arepanrix

split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs., Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 23/03/2010, , Revision: 1, Withdrawn, Last updated: 25/10/2011
List item

Human medicine European public assessment report (EPAR): Aripiprazole Accord

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 15/11/2015, , Revision: 15, Authorised, Last updated: 13/07/2022
List item

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 30/06/2015, , Revision: 16, Authorised, Last updated: 08/09/2023
List item

Human medicine European public assessment report (EPAR): Aripiprazole Sandoz

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/08/2015, , Revision: 9, Authorised, Last updated: 01/09/2022
List item

Human medicine European public assessment report (EPAR): Aripiprazole Zentiva

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 25/06/2015, , Revision: 9, Authorised, Last updated: 26/08/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019, , Revision: 5, Authorised, Last updated: 12/05/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide medac

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 17/09/2020, , Revision: 2, Authorised, Last updated: 26/04/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 01/04/2020, , Revision: 4, Authorised, Last updated: 29/03/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Krka

atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019, , Revision: 2, Authorised, Last updated: 07/06/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Mylan

atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016, , Revision: 14, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Atosiban SUN

atosiban (as acetate), Premature Birth
Date of authorisation: 31/07/2013, , Revision: 9, Authorised, Last updated: 09/02/2022

Load more

535 results

Human medicine European public assessment report (EPAR): Abecma

Human medicine European public assessment report (EPAR): Abiraterone Accord (updated)

Human medicine European public assessment report (EPAR): Abiraterone Krka

Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)

Human medicine European public assessment report (EPAR): Abrysvo (updated)

Human medicine European public assessment report (EPAR): Actelsar HCT

Human medicine European public assessment report (EPAR): Adakveo

Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)

Human medicine European public assessment report (EPAR): Ambrisentan Mylan

Human medicine European public assessment report (EPAR): Amifampridine SERB

Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan

Human medicine European public assessment report (EPAR): Amversio

Human medicine European public assessment report (EPAR): Anagrelide Mylan

Human medicine European public assessment report (EPAR): Apixaban Accord

Human medicine European public assessment report (EPAR): Arepanrix

Human medicine European public assessment report (EPAR): Aripiprazole Accord

Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)

Human medicine European public assessment report (EPAR): Aripiprazole Sandoz

Human medicine European public assessment report (EPAR): Aripiprazole Zentiva

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord

Human medicine European public assessment report (EPAR): Arsenic trioxide medac

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Human medicine European public assessment report (EPAR): Atazanavir Krka

Human medicine European public assessment report (EPAR): Atazanavir Mylan

Human medicine European public assessment report (EPAR): Atosiban SUN